Publications by authors named "Geert Maertens"

Claim this Profile
C
Characterization and Clinical Utility of Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma.
Piotr Rutkowski, Patrick Pauwels, Joseph Kerger, Bart Jacobs, Geert Maertens

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
Joan Maurel, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Antonieta Salud, Geert Maertens

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Filip Janku, Helen J Huang, Bart Claes, Gerald S Falchook, Siqing Fu, Geert Maertens

Mol Cancer Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma.
Max Schreuer, Geert Meersseman, Sari van Den Herrewegen, Yanina Jansen, Teofila Seremet, Geert Maertens

Melanoma Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen, Yanina Jansen, Ines Chevolet, Geert Maertens

J Transl Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere, Geert Maertens

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pathogen DNA isolation methods from large volumes of whole blood to improve molecular diagnosis of bloodstream infections.
Anne J M Loonen, Martine P Bos, Bart van Meerbergen, Sigi Neerken, Arnold Catsburg, Geert Maertens

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.
Babs E Verstrepen, Erik Depla, Christine S Rollier, Gwenny Mares, Joost A R Drexhage, Geert Maertens

J Infect Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
Mário G Pessôa, Venancio A F Alves, Alda Wakamatsu, Joaquim G Gomes, Geert Maertens

Liver Int· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GENimmune NV.
Geert Maertens, Lydie Meheus, Fred Shapiro, Annie van Broekhoven, Guy Buyens

Per Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection.
Geert Leroux-Roels, Arsène-Hélène Batens, Isabelle Desombere, Bart Van Den Steen, Christine Vander Stichele, Geert Maertens

Hum Vaccin· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus.
Yves Rouillé, François Helle, David Delgrange, Philippe Roingeard, Cécile Voisset, Geert Maertens

J Virol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Peter Simmonds, Jens Bukh, Christophe Combet, Gilbert Deléage, Nobuyuki Enomoto, Geert Maertens

Hepatology· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune response in acute hepatitis C virus infection.
Dale M Netski, Tim Mosbruger, Erik Depla, Geert Maertens, Stuart C Ray

Clin Infect Dis· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
Daniel Steinmann, Heidi Barth, Bettina Gissler, Peter Schürmann, Mohammed I Adah, Geert Maertens

J Virol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.
Geert Leroux-Roels, Erik Depla, Frank Hulstaert, Leen Tobback, Stéphanie Dincq, Geert Maertens

Vaccine· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B viral genotyping with the research INNO-LiPA HBV genotyping line probe assay.
Sija De Gendt, Fred Shapiro, Jelena Juras, Els Van Assche, Geert Maertens

Methods Mol Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.
Frederik Nevens, Tania Roskams, Hans Van Vlierberghe, Yves Horsmans, Dirk Sprengers, Geert Maertens

Hepatology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection.
Chris Verslype, Frederik Nevens, Nicoletta Sinelli, Carine Clarysse, Jacques Pirenne, Geert Maertens

J Hepatol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
Anna S F Lok, Fabien Zoulim, Stephen Locarnini, Alessandra Mangia, Grazia Niro, Geert Maertens

J Clin Microbiol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection model.
Saadia Bichr, Rosanna Rende-Fournier, Giovanna Vona, Ana-Maria Yamamoto, Erik Depla, Geert Maertens

J Gen Virol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Cosme Alvarado Esquivel, André Elewaut, Jan Philippé, Ann E Elewaut, Isabelle Desombere, Geert Maertens

Rev Invest Clin· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis